{"title":"Pharmacy and the Industry: A National Organization Perspective","authors":"L. Maine","doi":"10.3109/J058V18N02_07","DOIUrl":null,"url":null,"abstract":"SUMMARYNational pharmacy associations have worked with pharmaceutical manufacturers on a variety of programs and projects across the decades. Resources provided by the industry serve to support education, public relations programs, and special projects aimed at pharmacists and the general public. A variety of forces, including economic and political factors, have influenced how these collaborations are designed and the types of projects undertaken. Over time, the relationships and projects have changed from an “industry relations” strategy to more of a “return on investment” strategy. The industry and pharmacy organizations have much to gain by working together to help those who don't understand the value of well-designed and competently managed drug treatment plans to realize that medications are more than just a commodity to be acquired at the lowest possible price.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"62 1","pages":"63-73"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Marketing & Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/J058V18N02_07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
SUMMARYNational pharmacy associations have worked with pharmaceutical manufacturers on a variety of programs and projects across the decades. Resources provided by the industry serve to support education, public relations programs, and special projects aimed at pharmacists and the general public. A variety of forces, including economic and political factors, have influenced how these collaborations are designed and the types of projects undertaken. Over time, the relationships and projects have changed from an “industry relations” strategy to more of a “return on investment” strategy. The industry and pharmacy organizations have much to gain by working together to help those who don't understand the value of well-designed and competently managed drug treatment plans to realize that medications are more than just a commodity to be acquired at the lowest possible price.